The University of Hong Kong clinical trial pipeline

18 trials changed in the last 30 days: 0 stopped, 9 with notable changes, 9 with minor changes only.

1. Notable

   TACE and SBRT Followed by Double Immunotherapy for Downstaging…TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

   Primary completion pushed from Dec 1, 2024 to Dec 31, 2028

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Dec 1, 2026 to Dec 31, 2028

   The University of Hong Kong·Phase 2· NCT04988945· Registry history of NCT04988945 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

2. Notable

   RTMS Treatment of Spasticity · Cerebral Palsy/ Hemiplegia Due to…RTMS Treatment of Spasticity · Cerebral Palsy/ Hemiplegia Due to ABI - a RCT

   Primary completion pushed from May 2026 to Dec 2029

   Also in this update: Primary endpoint(s) modified; Study completion pushed from Aug 2026 to Dec 2029

   The University of Hong Kong·Not applicable· NCT06128746· Registry history of NCT06128746 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

3. Notable

   Immediate Effects of Self-Corrective Training in Adolescent…Immediate Effects of Self-Corrective Training in Adolescent Idiopathic Scoliosis: A Nested Study

   Primary endpoint(s) modified

   Also in this update: Trial completed; Final enrollment: 36 participants (planned 40)

   The University of Hong Kong·Not applicable· NCT07194564· Registry history of NCT07194564 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

4. Notable

   RFA vs MWA · Large Benign Thyroid Nodules, RCT

   Primary endpoint(s) modified

   Also in this update: Enrollment closed, study ongoing; Final enrollment: 50 participants (planned 25)

   The University of Hong Kong·Not applicable· NCT07804862· Registry history of NCT07804862 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

5. Notable

   Outcome and Future Liver Remnant Regenerative Response in…Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

   Phase changed: Phase 3 → not applicable

   Also in this update: Trial completed; Final enrollment: 20 participants (planned 40)

   The University of Hong Kong·Not applicable· NCT04868149· Registry history of NCT04868149 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

6. Notable

   RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19…RCT of Efficacy and Safety of CP003 on CFS/ME or Post COVID-19 Fatigue

   Recruitment opened

   Also in this update: Primary completion date changed from estimate of Jun 30, 2026 to Jan 15, 2026

   The University of Hong Kong·Phase 2/3· NCT06739720· Registry history of NCT06739720 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

7. Notable

   Health Products on Mood and Sleep Quality

   Recruitment opened

   The University of Hong Kong·Not applicable· NCT06579183· Registry history of NCT06579183 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

8. Notable

   Optimizing Chatbot Reminder Timing in a Chatbot Cessation Service…Optimizing Chatbot Reminder Timing in a Chatbot Cessation Service: A Micro-Randomized Trial

   Recruitment opened

   The University of Hong Kong·Not applicable· NCT07826884· Registry history of NCT07826884 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

9. Notable

   Dentine Hypersensitivity Using Dentine Adhesive With…Dentine Hypersensitivity Using Dentine Adhesive With Strontium-doped Bioactive Glass-Ceramic

   Recruitment opened

   The University of Hong Kong·Not applicable· NCT07628712· Registry history of NCT07628712 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.